Galmed Pharmaceuticals(GLMD) - 2018 Q4 - Earnings Call Transcript

Galmed Pharmaceuticals Ltd. (NASDAQ:GLMD) Q4 2018 Results Earnings Conference Call March 13, 2019 8:30 AM ET Company Participants Paul Arndt - Managing Director, LifeSci Advisors Allen Baharaff - Co-Founder, President, Chief Executive Officer Liat Hayardeny - Chief Scientific Officer Tali Gorfine - Chief Medical Officer Yohai Stenzler - Chief Financial Officer Conference Call Participants Steven Seedhouse - Raymond James Adam Walsh - Stifel Ed Arce - H.C. Wainwright Mayank Mamtani - B. Riley Caroline Palome ...